Site Search

1. 171.
   AMP/assets/File/awards/technologist/WinningAbstracts_Tech2014.pdf?pass=75

   Although the majority of nodules are classifiable, up to 30% of aspirated nodules fall into the ... seen in benign nodules, carry a 74% to 87% positive predictive value for malignancy. To maximize ... with the follicular variant of PTC. 100% concordance was observed between FNA smears and ... of detection of the assay is 5%. Conclusions: The FNA smear is a reliable

   https://www.amp.org/AMP/assets/File/awards/technologist/WinningAbstracts_Tech201...
2. 172.
   AMP/assets/File/position-statements/2016/AMPComments-Standards-NGS-FDA-2016-D...

   Instead of stating that PPA, NPA, and TPPV be set at no less than a point estimate of 99.9% with a lower bound of the 95% confidence interval of 99.0% or all variant types reported, the FDA should expand ... for reproducibility and repeatability that meet or exceed 95.0% for the lower bound of the 95% CI, calculated by conditions tested and genomic context,

   https://www.amp.org/AMP/assets/File/position-statements/2016/AMPComments-Standar...
3. 173.
   AMP/assets/File/resources/201503032014AssayValidationWhitePaper.pdf?pass=1

   Establish criteria for accepting results (e.g. >95% confidence interval, +/-2 SD) • The appropriate ... calculate mean value, standard deviation and %CV for within-run and between ... the manufacturer’s claim; if higher %CV were obtained, then evaluate the ... blank that will be detected 95% of the time with a 95% confidence interval. Can be determined by

   https://www.amp.org/AMP/assets/File/resources/201503032014AssayValidationWhitePa...
4. 174.
   Microsoft Word - AMPHCReformPrinciples_Final_June2009.doc

   information that informs 60-70% of treatment decisions. Members of the Association for ... delivery. While clinical laboratory tests comprise less than 5% of hospital costs and about 1.6% of all Association for Molecular Pathology Promoting Clinical ... of 4 Medicare costs, their findings influence 60-70% of health care decisions. Molecular tests account for a

   https://www.amp.org/AMP/assets/File/position-statements/2009/AMPHCReformPrincipl...
5. 175.
   Microsoft Word - 817557_1.DOC

   Pathologists (CAP) has nearly 16,000 physician members, including 91% of all eligible board- ... protein-bound homocysteine (about 70%), free homocysteine, the disulfide homocystine ... Report”]. For example, about 0.5% of the U.S. population ... Nutr. 279 (1992). Further, 20% of all vegetarians also have ... risk). 12 many as 50% of patients suffering from stroke

   https://www.amp.org/AMP/assets/File/position-statements/2006/LabCorpAmicus.pdf?p...
6. 176.
   Microsoft Word - H1N1PressRelease922009.doc

   a consensus response of 95%. In 2008 the consensus response was 100%. Approximately one third of the participating laboratories reported using user ... the first week of the H1N1 episode showed that 93% of the 43 respondents had a molecular assay that could ... commercial assays (ASR and IVD) in their laboratories, and 18% had non-commercial LDT’s in use. FDA cleared

   https://www.amp.org/AMP/assets/File/position-statements/2009/H1N1Statement.pdf?p...
7. 177.
   AMP/assets/File/clinical-practice/1124_39-41_AMPcase-Faraz-reprint-HiRes.pdf?pass=...

   Hemoglobin 11.0–14.7 g/dL 12.4 g/dL HCT 33.0–44.0% 37.8% MCV 82.3–93.2 fL 101.6 fL RDW 12.0–15.0% 16.5% PLT 130–350 10*3/μL 61 × 103/μL Table 1 2|CAP TODAYCytogenetic analysis. No mutations or pathogenic alterations were found in the following genes: FLT3, NPM1, IDH1, and IDH2.Treatment and outcomes. The patient underwent salvage chemotherapy

   https://www.amp.org/AMP/assets/File/clinical-practice/1124_39-41_AMPcase-Faraz-r...
8. 178.
   AMP/assets/File/awards/technologist/TechPosterAwards_WinningAbstracts_2016_000...

   The development of new therapies for HCV that cure more than 95% of patients, coupled with the ... Bone marrow aspirate showed about 40% abnormal “blast” appearing cells. Bone marrow ... lymphoid aggregates, contributing to about 40% of entire cellularity. The abnormal cells ... aspirate detected a population (about 50% of total events) of lambda monoclonal

   https://www.amp.org/AMP/assets/File/awards/technologist/TechPosterAwards_Winning...
9. 179.
   Detecting pathogens faster and more accurately by melting DNA - Association for...

   In this case, up to 30% of patients receive the wrong treatment, which ... essence, since the mortality risk increases by 4% every hour that the infection goes undiagnosed or ... due to sepsis-related complications. And 41% of these deaths occur in children. Early ... sepsis survival, as mortality risk rises by 4% for every hour the infection goes undiagnosed or

   https://www.amp.org/about/newsroom/amp-blog-content/detecting-pathogens-faster-a...
10. 180.
    AMP/assets/File/awards/technologist/Winning_TechPosters_Abstracts2018.pdf?pass=95

    Fusion showed an overall agreement of 99.7% (291/292). Percent positive agreement for each target was 100% for FluA (41/41), FluB (19/19), RSV (32/32 ... 39/39), and hRV (29/29), and was 96.9% (31/32) for P3. Four additional positives (3 hRV ... of cancer patients. The assay has a sensitivity of 0.1% mutation allelic fraction and can be designed for nearly any

    https://www.amp.org/AMP/assets/File/awards/technologist/Winning_TechPosters_Abst...